Skip to main content

Table 6 Univariate and multivariate Cox regression for OS of stage III–IV

From: Comparison of clinical characteristics and prognosis in endometrial carcinoma with different pathological types: a retrospective population-based study

Characteristics

No

Univariate analysis

Multivariate analysis

Hazard ratio (95% CI)

P

Hazard ratio (95% CI)

P

Age

77

1.042 (1.000—1.085)

0.052

0.977 (0.915–1.043)

0.480

Menopause

77

 

0.036

  

 No

15

Reference

 

Reference

 

 Yes

58

3.336 (0.775–14.360)

0.106

2.256 (0.282–18.033)

0.443

 Unknown

4

0.000 (0.000–Inf)

0.998

0.000 (0.000–Inf)

0.999

BMI

54

0.908 (0.757–1.089)

0.298

  

Chemotherapy

77

 

0.029

  

 No

15

Reference

 

Reference

 

 Yes

62

0.356 (0.149–0.851)

0.020

0.524 (0.183–1.497)

0.228

Radiotherapy

77

 

0.002

  

 No

42

Reference

 

Reference

 

 Yes

35

0.217 (0.073–0.641)

0.006

0.144 (0.044–0.464)

0.001

Myometrial infiltration (> = 1/2)

77

 

0.128

  

 No

25

Reference

   

 Yes

50

2.292 (0.765–6.870)

0.139

  

 Unknown

2

9.137 (0.989–84.410)

0.051

  

Lymph node metastasis

77

 

0.023

  

 No

15

Reference

 

Reference

 

 Yes

58

6.157 (0.823–46.057)

0.077

10.666 (1.303–87.304)

0.027

 Unknown

4

17.198 (1.535–192.721)

0.021

16.373 (1.302–205.940)

0.030

Pathological type

77

 

 < 0.001

  

 UEC

29

Reference

 

Reference

 

 UCCC

7

3.393 (0.563–20.450)

0.182

5.367 (0.692–41.590)

0.108

 USC

37

7.694 (2.206–26.830)

0.001

5.950 (1.613–21.951)

0.007

 UMC

4

0.000 (0.000–Inf)

0.998

0.000 (0.000–Inf)

0.998

  1. UEC uterine endometrioid carcinoma, USC uterine serous carcinoma, UMC uterine mixed carcinoma, UCCC uterine clear cell carcinoma, BMI body mass index, OS overall survival